The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial
Teunissen Jasmijn, Hochs Anne H.J., Vaessen-Verberne Anja, Boehmer Annemie L.M., Smeets Carien C.J.M., Brackel Hein, van Gent René, Wesseling Judith, Logtens-Stevens Danielle, de Moor Ronald, Rosias Philippe P.R., Potgieter Steph, Faber Marianne R., Hendriks Han J.E., Janssen-Heijnen Maryska L.G., Loza Bettina F.
Source: Eur Respir J 2014; 44: 913-921
Disease area: Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Teunissen Jasmijn, Hochs Anne H.J., Vaessen-Verberne Anja, Boehmer Annemie L.M., Smeets Carien C.J.M., Brackel Hein, van Gent René, Wesseling Judith, Logtens-Stevens Danielle, de Moor Ronald, Rosias Philippe P.R., Potgieter Steph, Faber Marianne R., Hendriks Han J.E., Janssen-Heijnen Maryska L.G., Loza Bettina F.. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J 2014; 44: 913-921
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Nebulised hypertonic (7%) saline improves quality of life in a blinded randomised cross-over trial Source: Annual Congress 2010 - Management of airway disease Year: 2010
Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS) Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
Double blind randomised placebo controlled study of effect of inhalation of (72% O2 and 28% helium) on perception of methacholine induced breathlessness in asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
Randomized, double blind, double dummy, placebo-controlled trial designed for comparing the effectiveness of formoterol (Foradil®) Aerolizer® and ipatropium bromide plus nebulized fenoterol (Berodual®) in asthma patients with ages ranging between 5 and 12 years who suffer acute asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012
BT10+ study design: 10 year follow-up of subjects receiving bronchial thermoplasty (BT) in 3 randomized controlled studies Source: International Congress 2017 – To freeze or heat? Year: 2017
A randomised, double-blind, placebo-controlled phase 3 study investigating the efficacy of nicotine substitution (NS) on nicotine withdrawal symptoms (NWS) in hospitalised smokers (HS) Source: Annual Congress 2009 - Smoking cessation Year: 2009
The effect of high dose N-acetylcysteine (1200mg daily) on airway function and airway trapping in COPD patients — A double blinded randomized placebo controlled trial Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
A double-blind trial of hyperosmolar saline as an adjunt to phsiotherapy in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001
RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021
A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia Source: Eur Respir J , 49 (2) 1601770; DOI: 10.1183/13993003.01770-2016 Year: 2017
Randomized clinical trial (RCT) comparing formoterol vs. salbutamol plus ipratropium bromide in the treatment of acute asthma exacerbation (AE) at emergency room (ER) Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
Fixed combination of glycopyrrolate and formoterol MDI (GFF-MDI) demonstrates superior inspiratory capacity (IC) compared to tiotropium DPI (Tio) following 7 days dosing, in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018
Whole body vibration training in long-term (>1 year) lung transplant patients – A randomized, controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Comparison against baseline in randomised control trials (again) Source: Eur Respir J 2014; 44: 1376 Year: 2014
Comparison against baseline in randomised control trials (again) Source: Eur Respir J 2014; 44: 1376-1377 Year: 2014